Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
West Vancouver, British Columbia, Canada
SEC filing record 1 source field available
Fiscal year end
31 July
BriaCell Therapeutics Corp. has filed 323 SEC EDGAR filings since 20 Jun 2014

SEC filing history

Showing 1-25 of 51 matching filings.

Per page
25
Current page
1
6-K File 001-40101

6-K filing

Filing date
18 Jul 2022
Reporting date
18 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
05 Jul 2022
Reporting date
05 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
29 Jun 2022
Reporting date
29 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
24 Jun 2022
Reporting date
24 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
18 May 2022
Reporting date
18 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
13 Apr 2022
Reporting date
13 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
12 Apr 2022
Reporting date
12 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
07 Apr 2022
Reporting date
07 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
28 Feb 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
23 Feb 2022
Reporting date
23 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
16 Feb 2022
Reporting date
16 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
10 Feb 2022
Reporting date
10 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
20 Jan 2022
Reporting date
20 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
05 Jan 2022
Reporting date
04 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
30 Dec 2021
Reporting date
30 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
17 Dec 2021
Reporting date
16 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
15 Dec 2021
Reporting date
15 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
09 Dec 2021
Reporting date
09 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
19 Nov 2021
Reporting date
18 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
12 Nov 2021
Reporting date
12 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
05 Nov 2021
Reporting date
05 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
02 Nov 2021
Reporting date
02 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40101

6-K filing

Filing date
29 Oct 2021
Reporting date
29 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .